Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells

by Elisa Cappuzzello, Pierangela Palmerini, Annavera Ventura, Andrea Visentin, Giuseppe Astori, Katia Chieregato, Valentina Mozzo, Omar Perbellini, Maria Chiara Tisi, Livio Trentin, Carlo Visco, Marco Ruggeri, Roberta Sommaggio, Antonio Rosato, Anna Dalla Pietà
Published 2021-07-01